Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccines under development: Helicobacter pylori].

Paul Harris D1, Carolina Serrano H, Alejandro Venegas E

  • 1Sección de Gastroenterología, Departamento de Pediatría, Facultad de Medicina, Pontificia Universidad Católica de Chile, Chile. pharris@med.puc.cl

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
|August 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Revista Chilena de Pediatria: From the paper to digital world].

Revista chilena de pediatria·2019
Same author

[20th Meeting of the Editors Group of the Journals of the Cono Sur Paediatric Societies].

Revista chilena de pediatria·2016
Same author

[Diagnosis of Helicobacter pylori infection in children based on stool antigen test].

Revista medica de Chile·2007
Same author

[Prospective evaluation of the safety and tolerance of colonoscopy in children].

Revista medica de Chile·2006

Developing a Helicobacter pylori vaccine is crucial due to widespread infection and antimicrobial resistance. Current animal models are insufficient, highlighting the need for a human model to advance vaccine development for gastrointestinal disease prevention.

Area of Science:

  • Gastroenterology and immunology
  • Vaccine development
  • Microbial pathogenesis

Background:

  • Helicobacter pylori infection is a major cause of peptic ulcers and gastric cancer globally.
  • Antimicrobial resistance, cost, and adverse effects limit traditional H. pylori eradication therapies.
  • The high prevalence and complications necessitate alternative strategies like vaccination.

Purpose of the Study:

  • To highlight the need for an effective H. pylori vaccine.
  • To evaluate the limitations of current animal models in H. pylori vaccine research.
  • To advocate for the development of a human model for H. pylori vaccine candidate selection.

Main Methods:

  • Review of existing literature on H. pylori infection and vaccine research.

Related Experiment Videos

  • Analysis of the efficacy and limitations of various animal models.
  • Identification of knowledge gaps in understanding H. pylori immunity and pathogenesis.

    • Main Results:

    • Existing animal models, except possibly non-human primates, have yielded controversial and insufficient results for vaccine development.
    • A significant gap exists in understanding H. pylori immunity and pathogenesis.
    • Current knowledge is insufficient to identify optimal vaccine candidates for field studies.

    Conclusions:

    • A human model is essential for selecting optimal H. pylori vaccine candidates.
    • Further research is required to understand H. pylori immunity and pathogenesis.
    • Field studies for advanced H. pylori vaccine candidates are currently not feasible due to insufficient knowledge and candidate development.